BioSpace News Archive

PerkinElmer Inc. , (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 43rd Annual Health Care Conference and the Barclays Global Healthcare Conference.

Cardio Diagnostics Holdings Inc to Debut PrecisionCHD ™ at the American College of Cardiology’s 72nd Annual Scientific Session.

Impact BioMedical and its research partner Global Research and Discovery Group today announced that they have finished the first phase of a groundbreaking project that could give humans the edge over cancer.

NanoVibronix, Inc., a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave technology, announced that it intends to launch a month to month rental program on March 1, 2023 for its lead products, PainShield and UroShield.

Heron Therapeutics, Inc. announced that it has entered into a cooperation agreement with two of its shareholders, Rubric Capital Management LP and Velan Capital Investment Management LP.

HALO Precision Diagnostics™ announced Christopher Hancock, MD, HALO’s neuroscience innovation officer, will receive the Edie Keller Leadership Award for his outstanding contributions to Alzheimer’s disease patient advocacy and clinical education from Alzheimers Coachella Valley at its annual Endless Possibilities event.

CYduct Diagnostics, Inc. recently attended the 11th International Symposium on the Human Breast hosted by Dr. Susan Love Foundation for Breast Cancer Research, a highly-regarded event dedicated to advancing the field of breast health.

BioDroneTM next-generation drug delivery platform honored for excellence alongside other innovators and innovations in the Health, Medical & Biotech category

The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will be participating in the H.C. Wainwright Cell Therapy Virtual Conference on February 28, 2023.